E Fund Management Hong Kong Co. Ltd. bought a new position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 468 shares of the medical research company’s stock, valued at approximately $111,000.
Other large investors also recently bought and sold shares of the company. Jennison Associates LLC lifted its holdings in IQVIA by 7.3% during the 1st quarter. Jennison Associates LLC now owns 140,914 shares of the medical research company’s stock worth $35,636,000 after buying an additional 9,578 shares during the last quarter. PGGM Investments lifted its holdings in IQVIA by 55.8% during the 2nd quarter. PGGM Investments now owns 12,073 shares of the medical research company’s stock worth $2,553,000 after buying an additional 4,326 shares during the last quarter. SG Americas Securities LLC lifted its holdings in IQVIA by 80.1% during the 1st quarter. SG Americas Securities LLC now owns 45,787 shares of the medical research company’s stock worth $11,579,000 after buying an additional 20,369 shares during the last quarter. Quadrature Capital Ltd bought a new position in IQVIA during the 1st quarter worth approximately $3,365,000. Finally, BNP Paribas bought a new stake in shares of IQVIA in the 1st quarter worth approximately $1,096,000. Institutional investors own 89.62% of the company’s stock.
IQVIA Stock Down 0.1 %
Shares of IQV stock opened at $216.04 on Thursday. IQVIA Holdings Inc. has a 1 year low of $167.42 and a 1 year high of $261.73. The stock has a market cap of $39.38 billion, a PE ratio of 28.06, a price-to-earnings-growth ratio of 2.09 and a beta of 1.49. The business’s fifty day moving average is $235.88 and its 200-day moving average is $230.06. The company has a debt-to-equity ratio of 1.80, a quick ratio of 0.85 and a current ratio of 0.85.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on IQV
Insider Activity
In other news, insider Eric Sherbet sold 1,300 shares of IQVIA stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the transaction, the insider now directly owns 19,536 shares in the company, valued at approximately $4,812,302.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.60% of the stock is owned by insiders.
IQVIA Company Profile
IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Read More
- Five stocks we like better than IQVIA
- High Flyers: 3 Natural Gas Stocks for March 2022
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Caterpillar Stock: Market Points to a Buying Opportunity
- How to Calculate Options Profits
- Big Buybacks Announced: 3 Stocks Insiders Are Banking On
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV – Free Report).
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.